LABCORP HOLDINGS INC. Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financial Liabilities
LABCORP HOLDINGS INC. (LH) reported Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financial Liabilities of $0 for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-10-29.
Financial Statements › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Provisional Information › Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments
us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities · last filed 2024-10-29
- LABCORP HOLDINGS INC. business combination, provisional information, initial accounting incomplete, adjustment, financial liabilities for the quarter ending 2024-09-30 was $0.00.
- LABCORP HOLDINGS INC. business combination, provisional information, initial accounting incomplete, adjustment, financial liabilities for the quarter ending 2024-06-30 was -$3.90M.
- LABCORP HOLDINGS INC. business combination, provisional information, initial accounting incomplete, adjustment, financial liabilities for the quarter ending 2024-03-31 was $0.00.
- LABCORP HOLDINGS INC. business combination, provisional information, initial accounting incomplete, adjustment, financial liabilities for the quarter ending 2023-03-31 was -$10.40M.
| Period end | Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financial Liabilities 3 month | Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financial Liabilities 6 month | Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financial Liabilities 9 month |
|---|---|---|---|
| 2024-09-30 | $0.00 10-Q · filed 2024-10-29 | -$3.90M derived: sum of 2 quarters · filed 2024-10-29 | -$3.90M derived: sum of 3 quarters · filed 2024-10-29 |
| 2024-06-30 | -$3.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | -$3.90M 10-Q · filed 2024-08-02 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-04-30 | ||
| 2023-03-31 | -$10.40M 10-Q · filed 2024-04-30 | ||
| 2022-09-30 | -$54.20M 10-Q · filed 2023-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |